Volume 4, Issue 1, Pages (January 1996)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 6, Issue 4, Pages (April 1997)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role.
Volume 8, Issue 2, Pages (February 1998)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 16, Issue 2, Pages (February 2002)
Volume 130, Issue 2, Pages (February 2006)
by Bindu Varghese, Adam Widman, James Do, Behnaz Taidi, Debra K
Volume 45, Issue 2, Pages (August 2016)
Volume 5, Issue 5, Pages (November 1996)
Volume 126, Issue 5, Pages (May 2004)
Volume 8, Issue 6, Pages (June 1998)
Volume 11, Issue 4, Pages (October 1999)
Volume 18, Issue 5, Pages (May 2003)
Constitutive Bcl-2 Expression during Immunoglobulin Heavy Chain–Promoted B Cell Differentiation Expands Novel Precursor B Cells  Faith Young, Emiko Mizoguchi,
Volume 5, Issue 2, Pages (August 1996)
Ananda W Goldrath, Michael J Bevan  Immunity 
Giandomenica Iezzi, Klaus Karjalainen, Antonio Lanzavecchia  Immunity 
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Volume 16, Issue 1, Pages (January 2002)
Volume 16, Issue 4, Pages (April 2002)
Volume 13, Issue 1, Pages (January 2006)
Volume 31, Issue 1, Pages (July 2009)
Volume 19, Issue 1, Pages (July 2003)
Alex Y.C Huang, Allen T Bruce, Drew M Pardoll, Hyam I Levitsky 
Differential Expression of the Ly49GB6, but Not the Ly49GBALB, Receptor Isoform during Natural Killer Cell Reconstitution after Hematopoietic Stem Cell.
Volume 27, Issue 2, Pages (August 2007)
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
Constitutive Bcl-2 Expression during Immunoglobulin Heavy Chain–Promoted B Cell Differentiation Expands Novel Precursor B Cells  Faith Young, Emiko Mizoguchi,
Volume 20, Issue 1, Pages (January 2004)
Volume 18, Issue 3, Pages (March 2003)
Sarah R. Guehler, Jeffrey A. Bluestone, Terrence A. Barrett 
Cisplatin augments cytotoxic T-lymphocyte–mediated antitumor immunity in poorly immunogenic murine lung cancer  Robert E Merritt, MD, Ali Mahtabifard,
Effector Cells Derived from Host CD8 Memory T Cells Mediate Rapid Resistance against Minor Histocompatibility Antigen-Mismatched Allogeneic Marrow Grafts.
Volume 14, Issue 1, Pages (January 2001)
Antisense Targeting of cFLIP Sensitizes Activated T Cells to Undergo Apoptosis and Desensitizes Responses to Contact Dermatitis  Dan V. Mourich, Jessica.
Volume 13, Issue 6, Pages (December 2000)
Volume 39, Issue 6, Pages (December 2003)
Volume 22, Issue 3, Pages (March 2005)
Volume 11, Issue 2, Pages (August 1999)
Interleukin-18 and the Costimulatory Molecule B7-1 Have a Synergistic Anti-Tumor Effect on Murine Melanoma; Implication of Combined Immunotherapy for.
Volume 18, Issue 5, Pages (May 2003)
Volume 25, Issue 5, Pages (November 2006)
Volume 4, Issue 3, Pages (March 1996)
Volume 14, Issue 5, Pages (May 2001)
Volume 12, Issue 5, Pages (November 2005)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 18, Issue 3, Pages (March 2003)
Negative Selection of Immature B Cells by Receptor Editing or Deletion Is Determined by Site of Antigen Encounter  Peter C Sandel, John G Monroe  Immunity 
Eric A Butz, Michael J Bevan  Immunity 
Volume 9, Issue 3, Pages (September 1998)
Volume 7, Issue 2, Pages (August 1997)
Volume 16, Issue 4, Pages (April 2002)
Alex Y.C Huang, Allen T Bruce, Drew M Pardoll, Hyam I Levitsky 
Volume 11, Issue 1, Pages (July 1999)
Volume 7, Issue 2, Pages (August 1997)
Volume 28, Issue 5, Pages (May 2008)
Volume 17, Issue 5, Pages (May 2009)
Volume 4, Issue 6, Pages (June 1996)
Volume 17, Issue 5, Pages (November 2002)
Volume 4, Issue 6, Pages (June 1996)
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 9, Issue 3, Pages (September 1998)
Volume 8, Issue 2, Pages (February 1998)
Volume 9, Issue 3, Pages (September 1998)
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Flow cytometric analysis of T cell activation.
Volume 19, Issue 4, Pages (October 2003)
Memory CD8+ T Cells Undergo Peripheral Tolerance
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Presentation transcript:

Volume 4, Issue 1, Pages 67-76 (January 1996) The Role of Ly49A and 5E6(Ly49C) Molecules in Hybrid Resistance Mediated by Murine Natural Killer Cells Against Normal T Cell Blasts  Yik Yeung Lawrence Yu, Thaddeus George, Jeffrey R Dorfman, Jacques Roland, Vinay Kumar, Michael Bennett  Immunity  Volume 4, Issue 1, Pages 67-76 (January 1996) DOI: 10.1016/S1074-7613(00)80299-X

Figure 1 Expression of Ly49A and 5E6 on NK Cells (NZB × B6) F1 spleen cells were cultured for 4 days, and were stained with PE-labeled anti-NK1.1, FITC-labeled anti-5E6, and biotinylated JR9–318 MAb plus RED670-conjugated streptavidin. The FACS profile of the triply stained cells gated on NK1.1+ subset (= 40% of total) is shown. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 2 Anti-SE6 and Anti-Ly49A Increase Lysis of B6 and BALB/c Targets, Respectively The triply stained (NZB × B6) F1 (H-2b/d) cells shown in Figure 1 were sorted into Ly49A+ 5E6− NK1.1+ and Ly49A− 5E6+ NK1.1+ subsets. The cells were tested against 51Cr-labeled B6 (H-2b) (A) or BALB/c (H-2d) (B) ConA blasts at the E:T ratios shown. Intact anti-5E6 MAb or (Fab′)2 A1 MAb was used to preincubate the effectors where indicated at a final concentration of 200 μg/ml. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 2 Anti-SE6 and Anti-Ly49A Increase Lysis of B6 and BALB/c Targets, Respectively The triply stained (NZB × B6) F1 (H-2b/d) cells shown in Figure 1 were sorted into Ly49A+ 5E6− NK1.1+ and Ly49A− 5E6+ NK1.1+ subsets. The cells were tested against 51Cr-labeled B6 (H-2b) (A) or BALB/c (H-2d) (B) ConA blasts at the E:T ratios shown. Intact anti-5E6 MAb or (Fab′)2 A1 MAb was used to preincubate the effectors where indicated at a final concentration of 200 μg/ml. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 3 (Fab′)2 Anti-5E6 MAb Abrogates the Resistance of ConA Blasts to Lysis by 5E6+ NK Cells 5E6+ cells were sorted from (NZB x B6) F1 (H-2b/d) spleen cells cultured for 4 days, as in Figure 2. The next day, the 5E6+ NK cells were tested against 51Cr-labeled B6 (H-2b), BALB/c (H-2d), or B10.D2(R107) (KbIbSbDdLd) targets at the E:T ratios shown. Where indicated, the effector cells had been preincubated with (Fab′)2 anti-5E6 MAb at a final concentration of 200 μg/ml. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 4 5E6+ NK Cells of F1 Mice Recognize H-2Kb Antigens Nylon wool nonadherent (BALB/c × B6) F1 (H-2b/d) splenocytes were cultured for 5 days, and were stained with PE-labeled anti-NK1.1 MAb and biotinylated anti-5E6 MAb. They were subsequently sorted into 5E6+ NK1.1+ or 5E6− NK1.1+ subsets. These effectors were tested 2 days later on 51Cr-labeled B6 ConA blasts at the E:T ratios shown. Where indicated, (Fab′)2 anti-Kb or anti-Db MAb was used to preincubate the targets at a final concentration of 100 μg/ml. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 5 5E6+ NK Cells Lyse Syngeneic B6 ConA Blasts in the Presence of (Fab′)2 Anti-5E6 MAb Cultured nylon wool nonadherent B6 (H-2b) spleen cells were sorted into the 5E6+ subset. The following day, some of the 5E6+ NK cells were preincubated with (Fab′)2 anti-5E6 MAb (75 μg/ml). Labeled B6 (H-2b) or BALB/c (H-2d) ConA blasts were incubated with 5E6+ BALB/c effectors with or without preincubation with (Fab′)2 anti-5E6 MAb at the E:T ratios indicated. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 6 The BALB-Encoded 5E6 Receptor Appears to be Inhibited by Both H-2b and H-2d Class I Antigens In two separate experiments, nylon wool nonadherent BALB/c (H-2d) (A) or BALB.B (H-2b) (B) splenocytes were cultured in IL-2 for 4 days before being sorted into 5E6+ cells. The day following each sort, the 5E6+ NK cells of BALB/c (A) or BALB.B (B) mice were tested against labeled BALB.B and BALB/c ConA blasts with or without preincubation with 75 μg/ml of (Fab′)2 anti-5E6 MAb at the E:T ratios indicated. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 6 The BALB-Encoded 5E6 Receptor Appears to be Inhibited by Both H-2b and H-2d Class I Antigens In two separate experiments, nylon wool nonadherent BALB/c (H-2d) (A) or BALB.B (H-2b) (B) splenocytes were cultured in IL-2 for 4 days before being sorted into 5E6+ cells. The day following each sort, the 5E6+ NK cells of BALB/c (A) or BALB.B (B) mice were tested against labeled BALB.B and BALB/c ConA blasts with or without preincubation with 75 μg/ml of (Fab′)2 anti-5E6 MAb at the E:T ratios indicated. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)

Figure 7 A Model to Explain Subset-Specific Lysis of H-2b and H-2d Targets by H-2b/d F1 NK Cells with the Missing Self Hypothesis NK cells have adhesion-type molecules by which they come into contact with all targets through the nonspecific ligand (NL) as indicated by the thick arrow. The NK cells from the H-2b/d F1 hybrid are subdivided into 5E6+ and Ly49A+ populations. 5E6+ NK cells have the H-2Kb receptor, and hence they do not reject B6 BMC. This is because the interaction between the H-2b receptor on the 5E6+ NK cells and H-2b class I antigen on H-2b or H-2b/d F1 targets delivers a negative signal (indicated by the thin arrow) to the NK cells, which prevents lysis or rejection from happening. No negative signal is sent when the 5E6+ NK cells interact with the BALB/c targets because they do not express H-2b. As a result, lysis proceeds. Similar reasoning explains why Ly49A+ NK cells lyse H-2b targets but not H-2d or H-2b/d F1 targets. Immunity 1996 4, 67-76DOI: (10.1016/S1074-7613(00)80299-X)